Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?

McMaster B. et al, (2024), Nat Methods

Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.

Ali M. et al, (2024), Clin Exp Immunol

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.

Satti I. et al, (2024), Lancet Infect Dis

Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT

Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.

Thornhill JP. et al, (2024), AIDS, 38, 679 - 688

Typhoid conjugate vaccines: a step towards typhoid control

Shakya M. and Pollard AJ., (2024), The Lancet Global Health, 12, e535 - e536

Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.

Martin NG. et al, (2024), J Infect, 88

Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study.

Schlapbach LJ. et al, (2024), Lancet Child Adolesc Health

Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy

Kenmoe S. et al, (2024), Journal of Infectious Diseases, 229, S51 - S60

Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

Lv X. et al, (2024), iScience, 27

Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance

Presser LD. et al, (2024), Journal of Infectious Diseases, 229, S34 - S39

Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review

Sheikh Z. et al, (2024), Journal of Infectious Diseases, 229, S8 - S17

Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host.

Florova M. et al, (2024), Proc Natl Acad Sci U S A, 121

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment.

Ma J. et al, (2024), Proc Natl Acad Sci U S A, 121

A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants.

Johnson M. et al, (2024), J Infect Dis, 229, S112 - S119

Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection.

Chappin K. et al, (2024), J Infect Dis, 229, S100 - S111

Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.

Ashton PM. et al, (2024), Lancet Microbe, 5, e226 - e234

Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis.

Deng S. et al, (2024), J Infect Dis, 229, S25 - S33

Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.

Osei-Yeboah R. et al, (2024), J Infect Dis, 229, S61 - S69

Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.

Osei-Yeboah R. et al, (2024), J Infect Dis, 229, S70 - S77

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?